Table of Contents Table of Contents
Previous Page  122 / 220 Next Page
Information
Show Menu
Previous Page 122 / 220 Next Page
Page Background

/

120

BLUE LABEL

INTEGRATED ANNUAL REPORT 2017

Notes

to the Group annual financial statements

continued

For the year ended 31 May 2017

2.

Group composition

continued

2.2 Investments in and loans to venture capital associates and joint venture

An associate and joint venture is accounted for as a venture capital investment where the Group has significant

influence in an associate or joint venture but the Group considers the investment to be a venture capital investment.

This is the case when the Group manages the investment on a fair value basis and has an exit strategy related to

the investment whereby the Group intends to recover the value of its investment through sale.

Critical accounting estimates and assumptions

IAS 28 exemption with respect to Oxigen Services India, Oxigen Online and 2DFine Holdings Mauritius.

The exemption available in IAS 28 –

Investments in Associates and Joint Ventures

has been applied to the

investment in Oxigen Services India, Oxigen Online and 2DFine Holdings Mauritius from 30 November 2016 and the

investment is accounted for in accordance with IAS 39 –

Financial Instruments: Recognition and Measurement

at

fair value with changes in fair value recognised in profit or loss. The differential between the carrying amount of the

investment (previously equity accounted for) and the fair value at this date is reflected as a gain on associate

measured at fair value in the Group income statement. Any additional changes in the fair value between

30 November 2016 and year-end have also been recognised in the Group income statement.

Oxigen Services India was demerged into two separate entities with effect from 1 June 2016. This was done in line

with the Group’s exit strategy to improve the marketability of these entities to potential investors.

Prior to 30 November 2016, the investment in Oxigen Services India was of a strategic nature as it was expected

to emulate the business model of the South African Distribution operations. The original decision to invest in this

business was because it was strategically aligned with other Blue Label distribution businesses in South Africa.

However, its profile has changed from that of the traditional Group business to one of generating growth in the

market value of the investment with a view to unlocking the Group’s share thereof. With the advent of its change

in focus to financial services through wallet subscription, it is no longer strategically aligned with the other business

units of the Group and is unlikely to generate profitability in the short to medium term. However, the market value

of the company is expected to increase exponentially in conjunction with its growth in wallet subscribers. This in

turn creates the potential to unlock the investment in value in the future and the Group is pursuing this new

strategy with respect to its investment in Oxigen Services India. In line with the Group’s exit strategy Oxigen Services

India was demerged into two separate entities with effect from 1 June 2016. This was done to improve the

marketability of these entities to potential investors.

2DFine Holdings Mauritius is an investment holding company that holds an effective interest in Oxigen Services

India and Oxigen Online.

Consequently, management reviews the results and operations of Oxigen Services India, Oxigen Online and

2DFine Holdings Mauritius on a fair value basis as opposed to the profits/losses that it generates. In addition,

management has established an exit strategy that looks to realise this fair value in the foreseeable future.

Accordingly, in accordance with IAS 28 –

Investments in Associates and Joint Ventures

Oxigen Services, India,

Oxigen Online and 2DFine Holdings Mauritius are viewed as venture capital investments which have been

accounted for at fair value through profit and loss from 30 November 2016 at which date equity accounting

ceased, in line with IFRS 13

Fair Value Measurement

.